Safety and clinical outcomes of intravenous thrombolysis in stroke mimics compared with acute ischemic stroke: A systematic review and meta-analysis.
Journal of Thrombosis and Thrombolysis · 2026-11-10 · Meta-analysis
Abstract
Intravenous thrombolysis (IVT) is the cornerstone of hyperacute care for acute ischemic stroke (AIS); however, increasingly compressed door-to-needle times mean some stroke mimics (SM) receive thrombolysis. We compared safety, mortality, functional, and disposition outcomes of IVT in SM versus confirmed AIS and assessed whether baseline neurological deficit severity modified these outcomes. We searched five databases up to June 2026 for IVT outcomes in adult SM versus AIS. We assessed risk of bias using the Newcastle-Ottawa Scale and the Cochrane Risk of Bias 2 (RoB-2) tool. We pooled 95% confidence intervals (CIs) using fixed- or random-effects models in R, with subgroup analyses by baseline National Institutes of Health Stroke Scale (NIHSS) score (≤ 7 versus > 7). Twenty-seven cohort studies and one RCT were included, involving approximately 285,000 patients. Compared with AIS, SM had significantly lower odds of symptomatic intracranial hemorrhage (OR 0.18; 95% CI 0.12-0.27), any intracranial hemorrhage (OR 0.12; 0.07-0.22), in-hospital mortality (OR 0.24; 0.06-0.94), and 3-month mortality (OR 0.24; 0.15-0.39). SM were also more likely to achieve functional independence (mRS 0-1) at discharge (OR 12.04) and 3 months (OR 3.50) and to be discharged home (OR 3.46), with shorter hospital stays (MD - 1.96 days). The hemorrhage reduction was greatest among milder deficits (NIHSS ≤ 7). IVT in stroke mimics carries substantially lower hemorrhagic and mortality risk and better functional outcomes than in AIS, reflecting the benign nature of mimics rather than a treatment effect. Diagnostic uncertainty should not delay or withhold IVT in otherwise eligible patients.
Abstract © the authors or publisher, via PubMed. Reuse and removal
Tags
Antithrombotics & thrombolytics · Thrombolytics · Mortality & survival · Quality of life & function
Related articles
- Intravenous Thrombolysis in Extracranial Arterial Dissection Stroke: A Meta-Analysis. (Can J Neurol Sci, 2026)
- Efficacy and Safety of Bridging Intravenous Thrombolysis in the "Drip-and-Ship" Model for Anterior and Posterior Circulation Stroke: A Systematic Review and Meta-Analysis. (J Vasc Interv Radiol, 2026)
- Tenecteplase, alteplase, and endovascular thrombectomy in extended-window acute ischemic stroke with intracranial large-vessel occlusion: a Bayesian network meta-analysis. (J Neurol, 2026)
- Clinical outcomes after intravenous thrombolysis for acute ischemic stroke in low- and middle-income countries: a pooled analysis of 67,917 patients and systematic review. (Neurol Res, 2026)
- Bridging Thrombolysis Versus Direct Endovascular Thrombectomy in Acute Ischemic Stroke Patients With ASPECTS ≤5: A Meta-Analysis. (Brain Behav, 2026)
- Intravenous thrombolysis use before interhospital transfer for thrombectomy: a systematic review and meta-analysis. (J Neurol, 2026)